{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:22:43Z","timestamp":1778030563139,"version":"3.51.4"},"reference-count":128,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.rbmo.2014.02.011","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T16:30:42Z","timestamp":1393950642000},"page":"669-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Basic research in PCOS: are we reaching new frontiers?"],"prefix":"10.1016","volume":"28","author":[{"given":"Izhar","family":"Ben-Shlomo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny S.","family":"Younis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2014.02.011_b0005","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.fertnstert.2007.11.093","article-title":"Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women","volume":"91","author":"Achrekar","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0010","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0015","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.lfs.2007.07.023","article-title":"Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population","volume":"81","author":"Baba","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.rbmo.2014.02.011_b0020","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/09513590902972042","article-title":"The contributions of resistin and adiponectin gene single nucleotide polymorphisms to the genetic risk for polycystic ovary syndrome in a Japanese population","volume":"25","author":"Baba","year":"2009","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.rbmo.2014.02.011_b0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/jc.2005-1804","article-title":"Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?","volume":"91","author":"Baillargeon","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0035","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00125-008-1028-6","article-title":"Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome","volume":"51","author":"Barber","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.rbmo.2014.02.011_b0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1472-6483(10)62053-6","article-title":"The polycystic ovary syndrome: what does insulin resistance have to do with it?","volume":"6","author":"Ben-Shlomo","year":"2003","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/humupd\/4.3.296","article-title":"Hyperandrogenic anovulation (the polycystic ovary syndrome) \u2013 back to the ovary?","volume":"4","author":"Ben-Shlomo","year":"1998","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2014.02.011_b0050","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1210\/endo.143.6.8851","article-title":"Perspective: the ovarian kaleidoscope database-II. Functional genomic analysis of an organ-specific database","volume":"143","author":"Ben-Shlomo","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2014.02.011_b0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1472-6483(10)60182-4","article-title":"Obesity-associated infertility \u2013 the earliest known description","volume":"17","author":"Ben-Shlomo","year":"2008","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0060","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.rbmo.2009.12.014","article-title":"Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS","volume":"20","author":"Celik","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10815-008-9280-8","article-title":"Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey","volume":"26","author":"Cetinkalp","year":"2009","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2014.02.011_b0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.rbmo.2014.02.011_b0075","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.rbmo.2012.01.009","article-title":"Influence of Val16Ala SOD2 polymorphism on the in-vitro effect of clomiphene citrate in oxidative metabolism","volume":"24","author":"Costa","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0080","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1071\/RD11201","article-title":"Different protein expression patterns associated with polycystic ovary syndrome in human follicular fluid during controlled ovarian hyperstimulation","volume":"24","author":"Dai","year":"2012","journal-title":"Reprod. Fertil. Dev."},{"key":"10.1016\/j.rbmo.2014.02.011_b0085","doi-asserted-by":"crossref","first-page":"e12401","DOI":"10.1371\/journal.pone.0012401","article-title":"Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with Polycystic Ovary Syndrome","volume":"5","author":"Dasgupta","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.rbmo.2014.02.011_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2010.06.083","article-title":"Efficacy of metformin therapy in adolescent girls with androgen excess: relation to sex hormone-binding globulin and androgen receptor polymorphisms","volume":"94","author":"Diaz","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0015-0282(16)57408-1","article-title":"Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy","volume":"63","author":"Donesky","year":"1995","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ymgme.2010.03.018","article-title":"Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome","volume":"100","author":"Du","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0105","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1210\/jcem.87.4.8385","article-title":"Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome","volume":"87","author":"Ehrmann","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1744-313X.2009.00867.x","article-title":"The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients","volume":"36","author":"Erdogan","year":"2009","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.rbmo.2014.02.011_b0115","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1472-6483(10)60596-2","article-title":"CYP1A1 gene polymorphism and polycystic ovary syndrome","volume":"16","author":"Esinler","year":"2008","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0120","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2009-2703","article-title":"Family-based analysis of candidate genes for polycystic ovary syndrome","volume":"95","author":"Ewens","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0125","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/humrep\/deq047","article-title":"Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome","volume":"25","author":"Fan","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rbmo.2011.10.010","article-title":"Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS","volume":"24","author":"Fan","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0140","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/S1472-6483(10)61071-1","article-title":"Oocyte in-vitro maturation: BCL2 mRNA content in cumulus cells reflects oocyte competency","volume":"19","author":"Filali","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0145","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jc.2005-2501","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria","volume":"91","author":"Franks","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0150","doi-asserted-by":"crossref","first-page":"E204","DOI":"10.1210\/jc.2010-0145","article-title":"Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome","volume":"95","author":"Gambineri","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0155","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.fertnstert.2006.11.041","article-title":"Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome","volume":"87","author":"Goodarzi","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0160","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.2337\/dc08-0532","article-title":"First evidence of genetic association between AKT2 and polycystic ovary syndrome","volume":"31","author":"Goodarzi","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rbmo.2014.02.011_b0165","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/humrep\/den065","article-title":"Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome","volume":"23","author":"Goodarzi","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/jmedgenet-2011-100427","article-title":"Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts","volume":"49","author":"Goodarzi","year":"2012","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.rbmo.2014.02.011_b0175","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.2337\/db08-0436","article-title":"Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123\/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes","volume":"57","author":"Grarup","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.rbmo.2014.02.011_b0180","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S1472-6483(10)60008-9","article-title":"Pro12Ala and His447His polymorphisms of PPAR-gamma are associated with polycystic ovary syndrome","volume":"18","author":"Gu","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0185","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/diacare.20.7.1087","article-title":"The homeostasis model in the San Antonio Heart Study","volume":"20","author":"Haffner","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rbmo.2014.02.011_b0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.rbmo.2011.02.015","article-title":"A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation","volume":"23","author":"Hanevik","year":"2011","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0195","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.fertnstert.2010.04.029","article-title":"Association of insulin receptor genetic variants with polycystic ovary syndrome in a population of women from Central Europe","volume":"94","author":"Hanzu","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0200","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/humrep\/des325","article-title":"Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome","volume":"27","author":"Haouzi","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/humupd\/dmq045","article-title":"Exercise therapy in polycystic ovary syndrome: a systematic review","volume":"17","author":"Harrison","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2014.02.011_b0210","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0015-0282(01)01691-0","article-title":"Apolipoprotein E alleles in women with polycystic ovary syndrome","volume":"75","author":"Heinonen","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0215","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1210\/en.2012-1145","article-title":"Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain","volume":"153","author":"Hirsch","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2014.02.011_b0220","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1210\/en.2010-1219","article-title":"Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary","volume":"152","author":"Hogg","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2014.02.011_b0225","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/en.2011-1607","article-title":"Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome","volume":"153","author":"Hogg","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2014.02.011_b0230","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/humrep\/det015","article-title":"The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study","volume":"28","author":"Homburg","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0235","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1210\/jc.2002-021791","article-title":"Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism","volume":"88","author":"Ibanez","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0240","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.lfs.2012.06.006","article-title":"Altered endothelin expression in granulosa-lutein cells of women with polycystic ovary syndrome","volume":"91","author":"Imbar","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.rbmo.2014.02.011_b0245","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymgme.2009.10.013","article-title":"Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis","volume":"99","author":"Ioannidis","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0250","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.fertnstert.2004.11.080","article-title":"Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome","volume":"83","author":"Jaaskelainen","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2350-10-139","article-title":"Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women","volume":"10","author":"Jin","year":"2009","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.rbmo.2014.02.011_b0260","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.fertnstert.2006.04.027","article-title":"Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome","volume":"86","author":"Jones","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0265","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1210\/jc.2009-0931","article-title":"Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene","volume":"94","author":"Jones","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0270","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1369\/jhc.2010.956615","article-title":"Fibrillins in adult human ovary and polycystic ovary syndrome: is fibrillin-3 affected in PCOS?","volume":"58","author":"Jordan","year":"2010","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.rbmo.2014.02.011_b0275","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cen.12137","article-title":"Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity","volume":"79","author":"Kahal","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.rbmo.2014.02.011_b0280","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12020-010-9370-0","article-title":"Methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish patients with polycystic ovary syndrome","volume":"38","author":"Karadeniz","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.rbmo.2014.02.011_b0285","doi-asserted-by":"crossref","first-page":"E2016","DOI":"10.1210\/jc.2011-3441","article-title":"Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis","volume":"97","author":"Kaur","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0290","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1089\/jwh.2009.1902","article-title":"Polymorphisms of the HSD17B6 and HSD17B5 genes in Chinese women with polycystic ovary syndrome","volume":"19","author":"Ke","year":"2010","journal-title":"J. Womens Health"},{"key":"10.1016\/j.rbmo.2014.02.011_b0295","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","article-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases","volume":"32","author":"Kiddy","year":"1990","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.rbmo.2014.02.011_b0300","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.fertnstert.2007.10.030","article-title":"Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome","volume":"90","author":"Kim","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0305","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.fertnstert.2008.12.040","article-title":"Estrogen receptor beta gene +1730 G\/A polymorphism in women with polycystic ovary syndrome","volume":"93","author":"Kim","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0310","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/00016340902859315","article-title":"Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome","volume":"88","author":"Kuscu","year":"2009","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.rbmo.2014.02.011_b0315","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.fertnstert.2008.06.023","article-title":"111\/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women","volume":"92","author":"Lee","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0320","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7827-7-73","article-title":"Study of RNA interference inhibiting rat ovarian androgen biosynthesis by depressing 17alpha-hydroxylase\/17, 20-lyase activity in vivo","volume":"7","author":"Li","year":"2009","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.rbmo.2014.02.011_b0325","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/molehr\/gaq087","article-title":"Association of rs10830963 and rs10830962 SNP in the melatonin receptor (MTNR1B) gene among Han Chinese women with polycystic ovary syndrome","volume":"17","author":"Li","year":"2011","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0330","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12020-008-9069-7","article-title":"Androgen receptor gene CAG(n) trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome","volume":"33","author":"Liu","year":"2008","journal-title":"Endocrine"},{"key":"10.1016\/j.rbmo.2014.02.011_b0335","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/en.2009-0663","article-title":"Functional effects of polymorphisms in the human gene encoding 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1): a sequence variant at the translation start of 11 beta-HSD1 alters enzyme levels","volume":"151","author":"Malavasi","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2014.02.011_b0340","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cca.2008.07.028","article-title":"Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women","volume":"398","author":"Marquez","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.rbmo.2014.02.011_b0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mrfmmm.2007.11.007","article-title":"Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance","volume":"639","author":"Moran","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.rbmo.2014.02.011_b0350","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12020-009-9268-x","article-title":"Interleukin 1 beta (IL-1beta) promoter C [-511] T polymorphism but not C [+3953] T polymorphism is associated with polycystic ovary syndrome","volume":"37","author":"Mu","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.rbmo.2014.02.011_b0355","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1530\/EJE-08-0932","article-title":"Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome","volume":"160","author":"Mukherjee","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.rbmo.2014.02.011_b0360","doi-asserted-by":"crossref","first-page":"E185","DOI":"10.1210\/jc.2012-2471","article-title":"Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry","volume":"98","author":"Mutharasan","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0365","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0370","first-page":"462","article-title":"Anti-Mullerian hormone \u2013 a prognostic marker for metformin therapy efficiency in the treatment of women with infertility and polycystic ovary syndrome","volume":"5","author":"Neagu","year":"2012","journal-title":"J. Med. Life"},{"key":"10.1016\/j.rbmo.2014.02.011_b0375","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rbmo.2014.02.011_b0380","first-page":"4075","article-title":"Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens","volume":"82","author":"Nestler","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0385","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0390","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1095\/biolreprod.109.082719","article-title":"Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep","volume":"82","author":"Ortega","year":"2010","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0395","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/09513590903215581","article-title":"Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial","volume":"26","author":"Otta","year":"2010","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.rbmo.2014.02.011_b0400","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/humrep\/des172","article-title":"Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo and in vitro oocyte maturation","volume":"27","author":"Ouandaogo","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0405","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2012.10.005","article-title":"Sheep models of polycystic ovary syndrome phenotype","volume":"373","author":"Padmanabhan","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.rbmo.2014.02.011_b0410","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0030-1249020","article-title":"Very high frequency of the polymorphism for the insulin receptor substrate 1 (IRS-1) at codon 972 (glycine972arginine) in Southern Italian women with polycystic ovary syndrome","volume":"42","author":"Pappalardo","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.rbmo.2014.02.011_b0415","first-page":"249","article-title":"Association study for single nucleotide polymorphisms in the CYP17A1 gene and polycystic ovary syndrome","volume":"22","author":"Park","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.rbmo.2014.02.011_b0420","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1472-6483(10)60927-3","article-title":"Role of changes in dietary habits in polycystic ovary syndrome","volume":"8","author":"Pasquali","year":"2004","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0425","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1071\/RD09190","article-title":"Association of AR rs6152G\/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women","volume":"22","author":"Peng","year":"2010","journal-title":"Reprod. Fertil. Dev."},{"key":"10.1016\/j.rbmo.2014.02.011_b0430","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/humrep\/des460","article-title":"Loss of LH-induced down-regulation of anti-Mullerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome","volume":"28","author":"Pierre","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0435","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/molehr\/gap072","article-title":"Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries","volume":"15","author":"Prodoehl","year":"2009","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0440","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1210\/en.2011-1974","article-title":"Insulin-stimulated glucose uptake occurs in specialized cells within the cumulus oocyte complex","volume":"153","author":"Purcell","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2014.02.011_b0445","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.fertnstert.2008.07.016","article-title":"CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome","volume":"92","author":"Pusalkar","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0450","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00109-012-0881-4","article-title":"A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells","volume":"90","author":"Qu","year":"2012","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.rbmo.2014.02.011_b0455","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.fertnstert.2010.05.047","article-title":"A variant in the fibrillin-3 gene is associated with TGF-beta and inhibin B levels in women with polycystic ovary syndrome","volume":"94","author":"Raja-Khan","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0460","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0465","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0470","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0009-9120(01)00245-4","article-title":"Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease","volume":"34","author":"Sabuncu","year":"2001","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.rbmo.2014.02.011_b0475","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rbmo.2012.10.011","article-title":"Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome","volume":"26","author":"Sang","year":"2013","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0480","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2265.2009.03679.x","article-title":"The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence","volume":"72","author":"San-Millan","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.rbmo.2014.02.011_b0485","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2008-0038","article-title":"Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome","volume":"93","author":"Shah","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0490","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.2384","article-title":"Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome","volume":"44","author":"Shi","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.rbmo.2014.02.011_b0495","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1471-0528.2010.02527.x","article-title":"Association study of four key folliculogenesis genes in polycystic ovary syndrome","volume":"117","author":"Sproul","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.rbmo.2014.02.011_b0500","doi-asserted-by":"crossref","first-page":"e3019","DOI":"10.1371\/journal.pone.0003019","article-title":"Novel meta-analysis-derived type 2 diabetes risk loci do not determine prediabetic phenotypes","volume":"3","author":"Staiger","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.rbmo.2014.02.011_b0505","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2337\/db09-0117","article-title":"Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men","volume":"58","author":"Stancakova","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.rbmo.2014.02.011_b0510","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2350-11-12","article-title":"Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS)","volume":"11","author":"Tan","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.rbmo.2014.02.011_b0515","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF03346648","article-title":"The relationship between CAG repeat length polymorphism and infertility in Southern Chinese Han women","volume":"33","author":"Tong","year":"2010","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.rbmo.2014.02.011_b0520","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1210\/jc.2007-0761","article-title":"Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype","volume":"92","author":"Urbanek","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0525","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/09513590802342841","article-title":"Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome","volume":"24","author":"Van Nieuwerburgh","year":"2008","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.rbmo.2014.02.011_b0530","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2362.2008.02022.x","article-title":"Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma","volume":"38","author":"Varga","year":"2008","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.rbmo.2014.02.011_b0535","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.fertnstert.2011.12.028","article-title":"Developmental programming: prenatal testosterone excess disrupts anti-Mullerian hormone expression in preantral and antral follicles","volume":"97","author":"Veiga-Lopez","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0540","doi-asserted-by":"crossref","first-page":"E836","DOI":"10.1152\/ajpendo.00584.2005","article-title":"Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians","volume":"292","author":"Vollmert","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0545","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2010.02.010","article-title":"Tumor necrosis factor alpha (-308), interleukin-6 (-174) and interleukin-10 (-1082) gene polymorphisms in polycystic ovary syndrome","volume":"150","author":"Vural","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.rbmo.2014.02.011_b0550","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.fertnstert.2007.06.016","article-title":"Association of genetic variants of insulin degrading enzyme with metabolic features in women with polycystic ovary syndrome","volume":"90","author":"Wang","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0555","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12020-009-9205-z","article-title":"Lack of an association between CYP1A1 gene Ile462Val polymorphism and polycystic ovary syndrome in Chinese","volume":"36","author":"Wang","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.rbmo.2014.02.011_b0560","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12020-009-9228-5","article-title":"FABP4: a novel candidate gene for polycystic ovary syndrome","volume":"36","author":"Wang","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.rbmo.2014.02.011_b0565","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.rbmo.2010.04.013","article-title":"Identification of novel missense mutations of GDF9 in Chinese women with polycystic ovary syndrome","volume":"21","author":"Wang","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0570","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.fertnstert.2010.01.059","article-title":"Common genetic variation in MTNR1B is associated with serum testosterone, glucose tolerance, and insulin secretion in polycystic ovary syndrome patients","volume":"94","author":"Wang","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0575","doi-asserted-by":"crossref","first-page":"E1342","DOI":"10.1210\/jc.2011-3478","article-title":"Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry","volume":"97","author":"Welt","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2014.02.011_b0580","doi-asserted-by":"crossref","first-page":"e48963","DOI":"10.1371\/journal.pone.0048963","article-title":"Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome","volume":"7","author":"Wickenheisser","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.rbmo.2014.02.011_b0585","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.rbmo.2012.10.014","article-title":"Microsatellite polymorphism in the fibrillin 3 gene and susceptibility to PCOS: a case-control study and meta-analysis","volume":"26","author":"Xie","year":"2013","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2014.02.011_b0590","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/humrep\/dem382","article-title":"The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome","volume":"23","author":"Xita","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2009.01.158","article-title":"Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome","volume":"94","author":"Xu","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0600","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.fertnstert.2009.09.042","article-title":"Genotype and haplotype determination of interleukin (IL) 1 beta (g. -511C>T and g. +3954C>T) and IL-1RN in polycystic ovary syndrome","volume":"94","author":"Yang","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2014.02.011_b0605","first-page":"w13071","article-title":"Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels","volume":"140","author":"Yessoufou","year":"2010","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.rbmo.2014.02.011_b0610","first-page":"669","article-title":"Association of single nucleotide polymorphisms in adiponectin and its receptor genes with polycystic ovary syndrome","volume":"54","author":"Yoshihara","year":"2009","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.rbmo.2014.02.011_b0620","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gene.2012.04.083","article-title":"Association between the Pro12Ala polymorphism of PPAR-gamma gene and the polycystic ovary syndrome: a meta-analysis of case-control studies","volume":"503","author":"Zhang","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.rbmo.2014.02.011_b0615","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/EJE-07-0576","article-title":"Association of +45G15G(T\/G) and +276(G\/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women","volume":"158","author":"Zhang","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.rbmo.2014.02.011_b0625","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/humrep\/der379","article-title":"Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"27","author":"Zhao","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2014.02.011_b0630","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000231520","article-title":"Family-based association study of the MCF2L2 gene and polycystic ovary syndrome","volume":"68","author":"Zheng","year":"2009","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.rbmo.2014.02.011_b0635","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10528-009-9308-5","article-title":"A 9-bp deletion homoplasmy in women with polycystic ovary syndrome revealed by mitochondrial genome-mutation screen","volume":"48","author":"Zhuo","year":"2010","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.rbmo.2014.02.011_b0640","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00404-012-2358-7","article-title":"Analysis of mitochondrial DNA sequence variants in patients with polycystic ovary syndrome","volume":"286","author":"Zhuo","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.rbmo.2014.02.011_b0030","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil. Steril."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648314001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648314001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T04:32:11Z","timestamp":1565238731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648314001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":128,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1472648314001254"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2014.02.011","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Basic research in PCOS: are we reaching new frontiers?","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2014.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}